Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Shareholders' Equity

v3.24.1
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Common Shares
Additional Paid-in Capital
Warrants
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Non-Controlling Interest
Total
Balance at beginning of period at Dec. 31, 2021 $ 854,952 $ 224,835 $ 952 $ 999 $ (856,248) $ 175 $ 225,665
Balance at beginning of period (in shares) at Dec. 31, 2021 374,082,759            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Share-based compensation   136         136
Warrants expired   156 (156)        
Issuance and vesting (forfeiture) of restricted share units $ 2,329           2,329
Issuance and vesting (forfeiture) of restricted share units (in shares) 3,432,632            
Shares reserved for performance awards $ 862           862
Comprehensive loss for the period       (11) (107,455) (9) (107,475)
Balance at end of the period at Dec. 31, 2022 $ 858,143 225,127 796 988 (963,703) 166 121,517
Balance at end of period (in shares) at Dec. 31, 2022 377,515,391            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Share-based compensation   56         56
Warrants expired   67 (67)        
Issuance and vesting (forfeiture) of restricted share units $ (487)           (487)
Issuance and vesting (forfeiture) of restricted share units (in shares) 7,318,155            
Shares reserved for contingent consideration $ (1,234)           (1,234)
Warrants issued as part of debt modification     5,106       5,106
CGSF/SFNY Divestiture           1,267 1,267
Comprehensive loss for the period       (15) (62,384) $ (1,433) (63,832)
Balance at end of the period at Dec. 31, 2023 $ 856,422 $ 225,250 $ 5,835 $ 973 $ (1,026,087)   $ 62,393
Balance at end of period (in shares) at Dec. 31, 2023 384,833,546